Novo Nordisk supplier gets another FDA warning
Pharma supplier Catalent, which has been contracted by Novo Nordisk to fill Wegovy syringes, has once again received criticism from the US health authorities.
by astrid sturlason, translated by daniel pedersen
The US Food and Drug Administration, FDA, has once again wagged its finger at Catalent, a Novo Nordisk supplier, writes Danish financial media Finans.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Analysts: Novo Nordisk's Wegovy relaunch must go smoothly
For subscribers
Novo turns to new factories to boost supply of obesity drug
For subscribers
.jpg&w=384&q=75)
